TOPIC
Current Management of Oral Cavity Precancerous conditions and Squamous Cell Carcinoma Surgery
SPEAKERS
Chi Tonglien Viet, DDS, MD, PhD, FACS
Nita Chainani- Wu, DMD, MPH, MS, PhD
CONTINUING EDUCATION
3 CE Unit (Core)
LEARNING OBJECTIVES
1. Name the risk factors associated with OSCC.
2. Describe the clinical management modalities for Oral Cavity Precancerous conditions and OSCC.
3. Describe the biopsy methods available to dental practitioners for a suspicious oral lesion.
SPEAKER BIOS:
Dr. Chi T. Viet, DDS, MD, PhD, FACS is a surgeon scientist focused on head and neck cancer management. She is an Associate Professor at Loma Linda University. She earned her DDS and PhD from University of California, San Francisco, and her MD from New York University, where she completed her Oral and Maxillofacial Surgery residency. She then went on to complete fellowship training in Head and Neck Surgical Oncology and Microvascular Reconstructive Surgery in Portland, Oregon. Her clinical practice is devoted to the comprehensive surgical management of patients with head and neck benign and malignant pathology and microvascular reconstruction.
Nita Chainani- Wu, DMD, MPH, MS, PhD received her DMD from the University of Pennsylvania. She then completed her specialty training in Oral Medicine and a Master's in Science in Oral Biology from the University of California, San Francisco (UCSF). She received her PhD in Epidemiology from the School of Public Health, University of California, Berkeley.
Nita Chainani-Wu is a Diplomate of the American Board of Oral Medicine. She has been in private practice limited to oral medicine in Sunnyvale and then Mountain View, California since 2000. She served as part-time faculty member at the School of Dentistry, University of California, San Francisco from 2001 to 2014. She was project director and senior scientist at the Preventive Medicine Research Institute from 2008-2010 where she was involved in epidemiologic research on lifestyle factors and chronic diseases including heart disease, diabetes and prostate cancer.
SPONSOR
* RSVP by 12 noon Mon Sep 11